Overview

ATAC - Arimidex, Tamoxifen Alone or in Combination

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to test whether Arimidex alone or in combination with Tamoxifen is beneficial in the treatment of breast cancer.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Anastrozole
Tamoxifen